Approaches to the Treatment of Initial Pseudomonas aeruginosa Infection in Children Who Have Cystic Fibrosis

摘要: Pseudomonas aeruginosa remains an important cause of pulmonary disease in patients who have cystic fibrosis. The development antimicrobial therapy directed against this organism has resulted the preservation lung function and improved longevity. Efficacy been demonstrated with agents administered via parenteral, inhaled, oral routes. optimal antibiotic regimen unclear. There is active effort to use randomized, controlled clinical trials rigorously test effective for eradication P young children or at least delay establishment chronic infection.